(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DA DEUTETRABENAZINA DE FÓRMULA (I) OU SAL FARMACEUTICAMENTE ACEITÁVEL DA MESMA E USO DE UM COMPOSTO COM A FÓRMULA (II) OU SAL FARMACEUTICAMENTE ACEITÁVEL DA MESMA

ArquivadaInvention PatentPCT · US2019066150

Application data

Number

112021011386

Type

Invention Patent

Filing

12/13/2019

Publication

08/31/2021

PCT

US2019066150

Progress at the INPI

  1. Filing12/13/19
  2. Publication08/31/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/18/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AUSPEX PHARMACEUTICALS, INC

US

See this company's full portfolio

Inventors

F. S. (pessoa física)

DE

J. S. (pessoa física)

CH

M. G. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/779,232 · 12/13/2018

US

62/801,450 · 02/05/2019

Abstract

DEUTETRABENAZINA PARA O TRATAMENTO DA DISCINESIA NA PARALISIA CEREBRAL.A divulgação é direcionada a métodos de tratamento de discinesia em paralisia cerebral em pacientes humanos usando deutetrabenazina e seus metabólitos ativos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

11/18/2025

RPI 2863

Parecer de pré-exame

#6.23

07/22/2025

RPI 2846

Notificação de entrada na fase nacional - PCT

#1.3

08/31/2021

RPI 2643

Alteração de dados cadastrais

#1.1

06/22/2021

RPI 2633

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.